Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
$2.73
+0.4%
$2.76
$1.69
$3.29
$490.01M2.032.08 million shs406,742 shs
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$2.20
$2.37
$0.85
$3.00
$423.23M2.0396,220 shs62,655 shs
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
$3.39
+4.3%
$3.06
$2.01
$6.53
$471.14M1.521.73 million shs2.51 million shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$11.95
+10.4%
$9.42
$1.40
$12.05
$482.42M1.43518,890 shs754,528 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
+0.37%+0.37%+5.00%+14.71%+7.91%
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
0.00%-3.93%-10.20%-7.56%+92.98%
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
+4.46%+18.71%+0.15%-9.71%-42.06%
LifeMD, Inc. stock logo
LFMD
LifeMD
+10.44%+23.20%+17.39%+103.58%+668.49%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
1.0918 of 5 stars
3.53.00.00.00.60.80.0
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
0.0787 of 5 stars
0.82.00.00.00.01.70.6
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
3.1717 of 5 stars
2.22.00.04.52.41.70.6
LifeMD, Inc. stock logo
LFMD
LifeMD
0.5133 of 5 stars
1.54.00.00.02.60.80.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
3.00
Buy$4.3358.73% Upside
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
1.67
Reduce$1.80-18.18% Downside
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
2.40
Hold$4.0519.47% Upside
LifeMD, Inc. stock logo
LFMD
LifeMD
3.00
Buy$10.40-12.97% Downside

Current Analyst Ratings

Latest CYH, ABUS, AVAH, and LFMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$3.25 ➝ $3.75
4/25/2024
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$5.50 ➝ $4.50
4/23/2024
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$13.00 ➝ $14.00
4/4/2024
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$4.00
3/18/2024
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$2.00 ➝ $3.00
3/15/2024
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$11.00 ➝ $13.00
3/6/2024
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$3.00
3/1/2024
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$6.00 ➝ $5.00
3/1/2024
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$4.00
2/22/2024
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$6.50 ➝ $5.50
(Data available from 4/27/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
$18.14M27.01N/AN/A$0.63 per share4.33
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
$1.90B0.22$0.58 per share3.82($0.68) per share-3.24
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
$12.49B0.04$2.47 per share1.37($8.68) per share-0.39
LifeMD, Inc. stock logo
LFMD
LifeMD
$152.55M3.16N/AN/A$0.15 per share79.67

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
-$72.85M-$0.44N/AN/AN/A-401.57%-57.82%-43.42%5/2/2024 (Confirmed)
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
-$134.52M-$0.71N/AN/AN/A-7.10%N/A-1.86%5/9/2024 (Confirmed)
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
-$133M-$0.95N/AN/AN/A-0.99%-5.51%-0.98%8/7/2024 (Estimated)
LifeMD, Inc. stock logo
LFMD
LifeMD
-$20.60M-$0.70N/AN/AN/A-14.01%N/A-50.74%5/8/2024 (Confirmed)

Latest CYH, ABUS, AVAH, and LFMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
-$0.0480N/A+$0.0480N/AN/AN/A  
5/8/2024N/A
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.13N/A+$0.13N/AN/AN/A  
5/2/2024N/A
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
-$0.10N/A+$0.10N/AN/AN/A  
4/24/2024Q1 2024
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
-$0.19-$0.14+$0.05$0.04$3.09 billion$3.14 billion    
3/14/2024Q4 2023
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
-$0.04-$0.02+$0.02$0.09$464.33 million$478.84 million
3/11/2024Q4 2023
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.14-$0.12+$0.02-$0.12$40.65 million$44.86 million
2/29/2024Q4 2023
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
-$0.12-$0.12N/A-$0.12$4.74 million$2.15 million    
2/21/2024Q4 2023
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
$0.03-$0.41-$0.44-$1.17$3.16 billion$3.18 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
N/AN/AN/AN/AN/A
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/AN/AN/AN/AN/A
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
N/A
5.87
5.87
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
N/A
0.89
0.89
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
N/A
1.49
1.34
LifeMD, Inc. stock logo
LFMD
LifeMD
3.22
1.22
1.15

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
43.79%
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
87.96%
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
84.99%
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%

Insider Ownership

CompanyInsider Ownership
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
5.40%
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
7.80%
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
9.90%
LifeMD, Inc. stock logo
LFMD
LifeMD
18.89%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Arbutus Biopharma Co. stock logo
ABUS
Arbutus Biopharma
73179.49 million169.80 millionOptionable
Aveanna Healthcare Holdings Inc. stock logo
AVAH
Aveanna Healthcare
33,500192.38 million177.37 millionOptionable
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
61,000138.98 million125.22 millionOptionable
LifeMD, Inc. stock logo
LFMD
LifeMD
20740.37 million32.74 millionOptionable

CYH, ABUS, AVAH, and LFMD Headlines

SourceHeadline
LifeMD to Report First Quarter 2024 Financial Results on May 8LifeMD to Report First Quarter 2024 Financial Results on May 8
globenewswire.com - April 24 at 8:00 AM
LifeMD (NASDAQ:LFMD) Price Target Increased to $14.00 by Analysts at BTIG ResearchLifeMD (NASDAQ:LFMD) Price Target Increased to $14.00 by Analysts at BTIG Research
americanbankingnews.com - April 24 at 4:44 AM
LifeMD to Participate in Upcoming Investor and Industry Conferences During MayLifeMD to Participate in Upcoming Investor and Industry Conferences During May
finance.yahoo.com - April 23 at 8:37 AM
LifeMD (NASDAQ:LFMD) Given New $14.00 Price Target at BTIG ResearchLifeMD (NASDAQ:LFMD) Given New $14.00 Price Target at BTIG Research
marketbeat.com - April 23 at 8:20 AM
LifeMD, Inc. (NASDAQ:LFMD) Sees Significant Growth in Short InterestLifeMD, Inc. (NASDAQ:LFMD) Sees Significant Growth in Short Interest
marketbeat.com - April 13 at 1:53 PM
Buy Rating Affirmed for LifeMD Amid Favorable Legal Outlook and Competitive StrengthsBuy Rating Affirmed for LifeMD Amid Favorable Legal Outlook and Competitive Strengths
markets.businessinsider.com - April 12 at 2:34 PM
Alkermes Sleeping Disorder Studies Data Look Excellent, Analyst SaysAlkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says
markets.businessinsider.com - April 9 at 2:56 PM
LifeMD, Inc. (NASDAQ:LFMD) Short Interest UpdateLifeMD, Inc. (NASDAQ:LFMD) Short Interest Update
marketbeat.com - March 29 at 8:18 PM
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceLifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
globenewswire.com - March 25 at 8:00 AM
LifeMD Shares Come Back to Life on GLP-1 Business GrowthLifeMD Shares Come Back to Life on GLP-1 Business Growth
marketbeat.com - March 19 at 6:05 AM
LifeMD Shares Come Back to Life on GLP-1 Business Growth LifeMD Shares Come Back to Life on GLP-1 Business Growth
marketbeat.com - March 19 at 6:05 AM
LifeMD Full Year 2023 Earnings: Beats ExpectationsLifeMD Full Year 2023 Earnings: Beats Expectations
finance.yahoo.com - March 13 at 6:20 PM
Can WeightWatchers Regain its Mojo after Oprah Steps Down?  (LFMD)Can WeightWatchers Regain its Mojo after Oprah Steps Down? (LFMD)
marketbeat.com - March 13 at 2:18 PM
Can WeightWatchers Regain Its Mojo after Oprah Steps Down?Can WeightWatchers Regain Its Mojo after Oprah Steps Down?
marketbeat.com - March 13 at 7:04 AM
LifeMD Poised for Growth: Strong Q4 Performance and Positive FY24 Outlook Reinforce Buy RatingLifeMD Poised for Growth: Strong Q4 Performance and Positive FY24 Outlook Reinforce Buy Rating
markets.businessinsider.com - March 12 at 3:28 PM
LifeMD Shares Jump on Strong 4QLifeMD Shares Jump on Strong 4Q
marketwatch.com - March 11 at 6:46 PM
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue EstimatesLifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates
zacks.com - March 11 at 6:31 PM
LifeMD Reports Fourth Quarter 2023 ResultsLifeMD Reports Fourth Quarter 2023 Results
globenewswire.com - March 11 at 4:05 PM
Heres what to expect from LifeMDs earningsHere's what to expect from LifeMD's earnings
markets.businessinsider.com - March 10 at 12:06 PM
Get Your Shopping List Ready: Heres How to Buy PullbacksGet Your Shopping List Ready: Here's How to Buy Pullbacks
realmoney.thestreet.com - March 5 at 12:26 PM
Hims & Hers Stock Rises On Stimulating Earnings Growth (LFMD)Hims & Hers Stock Rises On Stimulating Earnings Growth (LFMD)
marketbeat.com - March 5 at 6:05 AM
LifeMD Insiders Placed Bullish Bets Worth US$1.24mLifeMD Insiders Placed Bullish Bets Worth US$1.24m
finance.yahoo.com - February 27 at 10:21 AM
LifeMD to Report Fourth Quarter 2023 Financial Results on March 11LifeMD to Report Fourth Quarter 2023 Financial Results on March 11
finance.yahoo.com - February 26 at 8:54 AM
Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Tandem Diabetes Care (TNDM)Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Tandem Diabetes Care (TNDM)
markets.businessinsider.com - February 17 at 12:18 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Arbutus Biopharma logo

Arbutus Biopharma

NASDAQ:ABUS
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of imdusiran (AB-729), a proprietary subcutaneously-delivered RNAi therapeutic product candidate that suppresses all HBV antigens, including HBsAg expression. The company's research and development programs include AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune system; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has licensing agreements with Gritstone Oncology, Inc; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Barinthus Biotherapeutics plc to evaluate VTP-300. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.
Aveanna Healthcare logo

Aveanna Healthcare

NASDAQ:AVAH
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Community Health Systems logo

Community Health Systems

NYSE:CYH
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. The company was incorporated in 1996 and is headquartered in Franklin, Tennessee.
LifeMD logo

LifeMD

NASDAQ:LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.